What Researchers Did
Researchers conducted a retrospective analysis of patient charts to evaluate the hearing benefits of hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss (ISSHL).
What They Found
After 1-5 HBO sessions, 44.1% (N=102) of patients showed hearing improvement, with 67.6% of those with profound ISSHL improving. Patients receiving HBO within 12 days showed 6.484 times greater improvement compared to those treated later, though 6-10 sessions offered no additional benefit.
What This Means for Canadian Patients
Canadian patients with idiopathic sudden sensorineural hearing loss might benefit from hyperbaric oxygen therapy, especially if initiated within 12 days of symptom onset. This suggests that early intervention could significantly improve hearing outcomes for those affected.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
A limitation of this study is its retrospective design, which may introduce selection bias and limit generalizability.